Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

In the latest trading session, Amgen (AMGN) closed at $355.25, marking a -1.44% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the ...

Amgen stock has delivered a strong 73.5% return over the last three years, and the current checks suggest a mixed picture on ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The biotech and pharmaceutical mainstay posted its third-quarter results. It was a beat-and-raise quarter that featured double-digit growth on the top line. The quarter saw Amgen lift its total ...

It appears that some investors took a pair of new and bullish pundit takes to heart. In Jim Cramer's "Stop Trading" segment on CNBC's Squawk on the Street program, the famous stock picker mentioned ...

In June 2026, a Delaware jury ruled that Amgen and its subsidiary Teneobio willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704 in damages with the option to seek a ...

Pfizer and Amgen both grew revenue last quarter at nearly the same pace, but the engines driving that growth point toward two very different futures in oncology. One company is collecting cash from ...